THE US PREVENTIVE Services Task Force (USPSTF) concludes that evidence is insufficient to recommend routine screening for developmental dysplasia of the hip (DDH) in infants as a means to prevent adverse outcomes (I recommendation).* The pathophysiology and natural history of DDH are poorly understood. There is evidence that screening leads to earlier identification; however, 60% to 80% of the ...

The effect of genetic factors on hip dislocation, acetabular dysplasia, and developmental dysplasia of the hip (DDH) has long been recognized. In this report, we presented a large family that showed single gene inheritance for DDH. Pedigree analysis of a pregnant woman revealed a history of DDH in 16 members of the family. Although the pedigree showed autosomal dominant inheritance with reduced...

Background: During infancy, among developmental abnormalities of the hip joint, a broad-spectrum anomaly is dysplasia (DDH). To examine this abnormality, no standardized screening protocol available. Clinical examination most frequently followed, and in doubtful cases, ultrasound (US) used to confirm diagnosis. Aims: The present study aims compare sensitivity specificity clinical US neonatal de...

OBJECTIVE To evaluate the effect of successful external cephalic version on the incidence of developmental dysplasia of the hip (DDH) requiring treatment in singleton breech presentation at term. DESIGN Observational cohort study. SETTING Three large teaching hospitals in the Netherlands. POPULATION Women with a singleton breech presentation of 34 weeks of gestation or more, who underwent...

BACKGROUND Some etiological factors involved in developmental dysplasia of the hip (DDH) occur in the last trimester of pregnancy, which could result in a decreased incidence of DDH in preterm infants. The aim of this study was to compare the incidence of DDH between preterm and term infants. METHODS Ultrasound of the hip joint was performed in 2,534 term infants and 376 preterm infants withi...

PURPOSE: There is no consensus in the literature regarding the diagnosis and treatment of developmental dysplasia of the hip (DDH). We designed a national questionnaire to assess the various opinions and current practice of paediatric orthopaedic surgeons in the Netherlands regarding the diagnosis and treatment of DDH in children less than 1 year old. METHODS: The questionnaire was sent to all...

developmental dysplasia of the hip (ddh) or congenital hip dysplasia (cdh) is the most prevalent developmental childhood hip disorder. it includes a wide spectrum of hip abnormalities ranging from dysplasia to subluxation and complete dislocation of the hip joint. the natural history of neglected ddh in adults is highly variable. the mean age of onset of symptoms is 34.5 years for dysplastic dd...

BACKGROUND Developmental dysplasia of the hip (DDH) represents a spectrum of anatomic abnormalities that can result in permanent disability. OBJECTIVE We sought to gather and synthesize the published evidence regarding screening for DDH by primary care providers. METHODS We performed a systematic review of the literature by using a best-evidence approach as used by the US Preventive Service...

BACKGROUND It has been postulated that developmental dysplasia of the hip (DDH) is more frequent in infants born in the winter months. It was the purpose of this study to ascertain if there was any seasonal variation in DDH at the author's institution and compare/contrast our results with those in the literature using rigorous mathematical fitting. METHODS All children with DDH treated at the...

Developmental dysplasia of the hip (DDH) encompasses a wide spectrum of clinical severity, from mild developmental abnormalities to frank dislocation. Clinical hip instability occurs in 1% to 2% of full-term infants, and up to 15% have hip instability or hip immaturity detectable by imaging studies. Hip dysplasia is the most common cause of hip arthritis in women younger than 40 years and accou...